BEUDAMED
    FDA Adverse Event Injury Summary report: N

    UNKNOWN LIGASURE INSTRUMENT

    MDR report key: 16027907 · Received December 21, 2022

    Report

    Report Number
    1717344-2022-01579
    Event Type
    Injury
    Date Received
    December 21, 2022
    Date of Event
    July 1, 2022
    Report Date
    December 21, 2022
    Manufacturer
    COVIDIEN MFG DC BOULDER
    Product Code
    GEI
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    OH, US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    TITLE: LIVING DONOR LIVER TRANSPLANTATION WITH AUGMENTED VENOUS OUTFLOW AND SPLENECTOMY: A PROMISED LAND FOR SMALL LEFT LOBE GRAFTS SOURCE: ANNALS OF SURGERY VOLUME 276, NUMBER 5, NOVEMBER 2022 LDLT WITH AUGMENTED OUTFLOW AND SPLENECTOMY. MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Description of Event or Problem · 0

    ACCORDING TO THE LITERATURE, LIVING DONOR LIVER TRANSPLANTATION (LDLT) USING SMALL GRAFTS, ESPECIALLY LEFT LOBE GRAFTS (H1234-MHV) (LLG), CONTINUES TO BE A CHALLENGE DUE TO SMALL-FOR-SIZE SYNDROME (SFSS). THE STUDY DEMONSTRATES THAT WITH SURGICAL MODIFICATIONS, OUTCOMES WITH SMALL GRAFTS CAN BE IMPROVED. METHODS: BETWEEN 2012 AND 2020, WE PERFORMED 130 ADULT LDLT; SPLENECTOMY WAS PERFORMED WITH LIGASURE ATLAS IN 72 (56%) RECIPIENTS FOR INFLOW MODULATION AND COMPARED TO PATIENTS THAT DIDN'T RECEIVE SPLENECTOMY. INTRAOPERATIVE PACKED RED BLOOD CELLS (PRBC) TRANSFUSION TENDED TO BE HIGHER IN THE SPLENECTOMY GROUP (WITH LIGASURE) BUT THE DIFFERENCE DIDN¿T REACH STATISTICAL SIGNIFICANCE. THERE WAS NO ADDITIONAL DATA PROVIDED ON THE NUMBER OF PATIENTS RECEIVING TRANSFUSION.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1406973 UNKNOWN LIGASURE INSTRUMENT ELECTROSURGICAL, CUTTING & COAGULATION & ACCES GEI COVIDIEN MFG DC BOULDER UNKNOWN LIGASURE INSTRUMENT

    Patients

    Seq Age Sex Outcome Treatment
    1 46 YR Unknown Required Intervention